EQT Life Sciences

Overview

EQT Life Sciences is a prominent European venture capital firm specializing in life sciences investments. The firm focuses on early-to-late-stage companies developing innovative therapeutics, medical devices, diagnostics, and healthtech solutions. With a history spanning over 30 years, EQT Life Sciences has raised approximately €3.5 billion across 12 private funds and 3 investment strategies. The firm's geographical focus includes Europe and occasionally the United States. EQT Life Sciences has a dedicated team of experienced investment professionals with backgrounds in medicine and science, aiming to back inventors with ideas that could make a significant difference for patients. The firm's portfolio includes over 65 companies, and it has raised around €3.5 billion across 12 funds. EQT Life Sciences is committed to transforming cutting-edge scientific innovation into impactful healthcare solutions to address unmet clinical needs. The firm's investment philosophy emphasizes identifying innovative solutions to significant clinical challenges and consistently striving for superior returns for investors. EQT Life Sciences is also an active contributor to the life sciences industry through roles as founder and board member of the Oncode Institute, initiator of the Dutch Venture Initiative (DVI), and board member of European venture capital associations, technology transfer institutes, and government bodies.

Investment Focus

• Innovative life sciences companies developing therapeutics, medical devices, diagnostics, and healthtech solutions

Portfolio Companies